Tag Archives: CEO Global Generics M.V

Reddy’s Laboratories on Tuesday said it is foraying into the biosimilar immuno-oncology therapy

Reddy’s Laboratories on Tuesday said it is foraying into the biosimilar immuno-oncology therapy segment in [...]